End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,220 KRW | -4.12% | -16.20% | -23.30% |
2023 | Vaxcell-Bio Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2021 | Vaxcell-Bio Therapeutics Co., Ltd.(KOSDAQ:A323990) added to S&P Global BMI Index | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
286M | - | - | - | - | - | |
118B | ||||||
106B | ||||||
24.28B | - | |||||
21.96B | - | |||||
18.16B |